What is the treatment for a patient with a 13mm x 15mm parenchymal hemorrhage in the medial posterior left temporal lobe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Small Parenchymal Hemorrhage in the Medial Posterior Left Temporal Lobe

For a 13mm x 15mm parenchymal hemorrhage in the medial posterior left temporal lobe, conservative medical management with close neurological monitoring is the appropriate treatment approach, as this small hemorrhage does not meet criteria for surgical intervention.

Initial Diagnostic Evaluation

Obtain non-contrast CT head immediately to confirm the hemorrhage and assess for mass effect, midline shift, or intraventricular extension 1. CT without contrast remains the gold standard for detecting acute parenchymal hemorrhage 1.

Follow with MRI brain with and without contrast (or CTA head) to identify underlying vascular malformations, tumors, or other structural causes 1. This is critical because:

  • Temporal lobe hemorrhages in younger patients may indicate arteriovenous malformations 2, 3
  • Lack of enhancement helps exclude intermediate or high-grade tumors 4
  • Vascular imaging should be performed to evaluate for aneurysms, AVMs, or venous thrombosis 1

Medical Management Strategy

Admit to intensive care unit or stroke unit for continuous neurological monitoring 1. Serial neurological examinations are essential as clinical deterioration may occur despite initial stability 5.

Blood Pressure Management

  • Maintain careful blood pressure control to ensure adequate cerebral perfusion (mean arterial pressure >65-70 mmHg) while avoiding hypertension that could worsen bleeding 5
  • Avoid vasopressors when possible 1
  • Monitor for signs of increased intracranial pressure 2

Coagulation Management

  • Obtain baseline coagulation studies: PT, aPTT, platelet count, and fibrinogen level 1
  • Reverse any anticoagulation immediately
  • Correct coagulopathy aggressively if present 1

Supportive Care

  • Monitor for seizures and consider prophylactic antiepileptic therapy, particularly given the temporal lobe location where seizures are a common presentation 3, 6
  • Maintain normothermia 1
  • Ensure adequate oxygenation 1

Monitoring Protocol

Perform repeat CT imaging at 24 hours to assess for hematoma expansion 1. Additional imaging should be obtained if:

  • Abrupt neurological deterioration occurs 1
  • New focal deficits develop 1
  • Level of consciousness declines 1

Serial NIHSS scores should be documented at baseline, 24 hours, 72 hours, 7-10 days, 30 days, and 90 days 1.

When Surgery Is NOT Indicated

This 13-15mm hemorrhage does not require surgical evacuation because:

  • Hemorrhages of this size (1.3-1.5 cm) typically resolve spontaneously with good clinical outcomes 6
  • Surgical intervention for intracerebral hemorrhage is generally reserved for larger hematomas with significant mass effect or clinical deterioration 1, 5
  • Posterior temporal hemorrhages of similar size (1.8-2.8 cm) have demonstrated excellent outcomes with conservative management 6

Expected Clinical Presentation and Prognosis

Right-sided posterior temporal hemorrhages typically present with headache and confusion without prominent lateralizing deficits 6. Left-sided lesions may cause Wernicke-type aphasia 6.

Prognosis for hemorrhages of this size is generally favorable, with factors affecting outcome including:

  • Patient age and baseline neurological condition 2
  • Hemorrhage location (corpus callosum involvement carries worse prognosis) 7
  • Rate of hematoma formation 2
  • Presence of intraventricular extension 7

Critical Pitfalls to Avoid

  • Do not assume the hemorrhage is hypertensive without vascular imaging, especially in younger patients where AVMs are more common 2, 3
  • Do not delay neurosurgical consultation if the patient develops neurological deterioration, as this may indicate hematoma expansion requiring intervention 5
  • Do not overlook the need for venous thrombosis evaluation if imaging shows atypical features, as cortical vein thrombosis can present with temporal lobe hemorrhage 1
  • Do not start venous thromboprophylaxis until bleeding has stabilized, though it should be commenced as soon as safely possible given the prothrombotic state that develops 1

Follow-Up Care

Functional outcome assessment should be performed at 7-10 days, 30 days, and 90 days using modified Rankin Scale and Barthel Index 1. Most deficits from small temporal hemorrhages improve significantly over subsequent months 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intraparenchymal hemorrhage.

New horizons (Baltimore, Md.), 1997

Research

Pleomorphic xanthoastrocytoma presenting with massive intracranial hemorrhage.

AJNR. American journal of neuroradiology, 1996

Guideline

Management of Symptomatic Subdural Hematoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nontraumatic posterior temporal lobe hemorrhage: clinical computed tomographic correlations.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.